Espinoza J, Bizama C, Garcia P, Ferreccio C, Javle M, Miquel J
Biochim Biophys Acta. 2016; 1865(2):245-54.
PMID: 26980625
PMC: 6287912.
DOI: 10.1016/j.bbcan.2016.03.004.
Chen Y, Kong J, Wu S
Lab Invest. 2014; 95(2):124-31.
PMID: 25502177
DOI: 10.1038/labinvest.2014.140.
Akatsu T, Yoshida M, Kubota T, Shimazu M, Ueda M, Otani Y
World J Surg. 2005; 29(2):182-6.
PMID: 15654665
DOI: 10.1007/s00268-004-7482-5.
Devesa F, Ferrando J, Caldentey M, Borghol A, Moreno M, Nolasco A
Dig Dis Sci. 2001; 46(7):1424-36.
PMID: 11478494
DOI: 10.1023/a:1010631619162.
Hood K, Gleeson D, Ruppin D, Dowling R
Gut. 1993; 34(9):1277-88.
PMID: 8406169
PMC: 1375471.
DOI: 10.1136/gut.34.9.1277.
Indomethacin decreases viscosity of gallbladder bile in patients with cholesterol gallstone disease.
von Ritter C, Niemeyer A, Lange V, Mohrle W, Richter W, Von Meyer L
Clin Investig. 1993; 71(11):928-32.
PMID: 8312687
DOI: 10.1007/BF00185606.
Percutaneous cholecystolithotomy: is gall stone recurrence inevitable?.
Donald J, Cheslyn-Curtis S, Gillams A, Russell R, Lees W
Gut. 1994; 35(5):692-5.
PMID: 8200568
PMC: 1374759.
DOI: 10.1136/gut.35.5.692.
Biosynthesis of a human gall-bladder mucin.
Klomp L, de Lely A, Strous G
Biochem J. 1994; 304 ( Pt 3):737-44.
PMID: 7818475
PMC: 1137396.
DOI: 10.1042/bj3040737.
Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double-blind, placebo-controlled trial of two dosage schedules.
Das A, Baijal S, Saraswat V
Dig Dis Sci. 1995; 40(8):1782-5.
PMID: 7648980
DOI: 10.1007/BF02212702.
Effect of NSAIDs on gallbladder bile composition.
Sterling R, Shiffman M, Sugerman H, Moore E
Dig Dis Sci. 1995; 40(10):2220-6.
PMID: 7587793
DOI: 10.1007/BF02209010.
Pharmacological treatment of gallstones. Practical guidelines.
Lanzini A, Northfield T
Drugs. 1994; 47(3):458-70.
PMID: 7514975
DOI: 10.2165/00003495-199447030-00006.
Extracorporeal biliary lithotripsy and direct chemolitholysis-an integrated concept.
Domschke W
Gastroenterol Jpn. 1989; 24(5):597-604.
PMID: 2680747
DOI: 10.1007/BF02773895.
Restraint urged for biliary lithotripsy.
Flick A
Dig Dis Sci. 1990; 35(7):916-8.
PMID: 2364849
DOI: 10.1007/BF01536810.
Interactions between gall bladder bile and mucosa; relevance to gall stone formation.
Jacyna M
Gut. 1990; 31(5):568-70.
PMID: 2190868
PMC: 1378579.
DOI: 10.1136/gut.31.5.568.
Non-surgical options for the management of gallstone disease: an overview.
Cuschieri A
Surg Endosc. 1990; 4(3):127-31; discussion 136-40.
PMID: 2148441
DOI: 10.1007/BF02336587.
One gram of aspirin per day does not reduce risk of hospitalization for gallstone disease.
Kurata J, Marks J, Abbey D
Dig Dis Sci. 1991; 36(8):1110-5.
PMID: 1864205
DOI: 10.1007/BF01297455.
Dissolution of cholesterol gall stones using methyltertbutyl ether: a safe effective treatment.
McNulty J, Chua A, Keating J, Weir D, Keeling P
Gut. 1991; 32(12):1550-3.
PMID: 1773965
PMC: 1379261.
DOI: 10.1136/gut.32.12.1550.
Nonsteroidal anti-inflammatory drugs and gallstone formation.
Famaey J
Clin Rheumatol. 1992; 11(2):288.
PMID: 1617907
DOI: 10.1007/BF02207975.
Effect of indomethacin and misoprostol on fasted gallbladder volume and meal-induced gallbladder contractility in humans.
Murray F, Stinchcombe S, Hawkey C
Dig Dis Sci. 1992; 37(8):1228-31.
PMID: 1499446
DOI: 10.1007/BF01296564.
Mucus glycoprotein biosynthesis in the human gall bladder: inhibition by aspirin.
Rhodes M, Allen A, Lennard T
Gut. 1992; 33(8):1109-12.
PMID: 1398237
PMC: 1379452.
DOI: 10.1136/gut.33.8.1109.